Regulation of human apolipoprotein A-I gene expression by gramoxone.

The Journal of Biological Chemistry
C CuthbertS P Tam

Abstract

To induce oxidative stress, HepG2 cells were exposed to a compound known as gramoxone. This compound undergoes a one-electron reduction to form a stable free radical which is capable of generating reactive oxygen species. We demonstrated that exposure of HepG2 cells to gramoxone (0.1 microM) resulted in a 2-fold decrease in apoA-I mRNA with no significant change in apoB and apoE mRNA levels. To examine if increased rates of mRNA degradation were responsible for the reduction in apoA-I mRNA levels, mRNA half-lives were measured in the presence of actinomycin D with and without gramoxone treatment. These studies revealed a 4-fold increase in the rate of apoA-I mRNA degradation in cells exposed to gramoxone. In similarly treated cells, nuclear run-off assays indicated that the transcription rate of the apoA-I gene was also increased 2-fold. Consistent with nuclear run-off assays, transient transfection experiments using a series of pGL2-derived luciferase reporter plasmids containing the human apoAI proximal promoter demonstrated that gramoxone treatment increased apoA-I promoter activity 2-fold. We have identified a potential "antioxidant response element" (ARE) in the apoA-I promoter region that may be responsible for the increa...Continue Reading

References

Feb 22, 1975·Lancet·C WilhelmssonL Wilhelmsen
Jan 1, 1992·Progress in Lipid Research·S Parthasarathy, S M Rankin
Jul 29, 1991·FEBS Letters·M I MacknessP N Durrington
Aug 15, 1991·Archives of Biochemistry and Biophysics·J A DeGrayR P Mason
Mar 1, 1990·The Journal of Clinical Investigation·W StroblW Patsch
May 22, 1990·Biochimica Et Biophysica Acta·S ParthasarathyL G Fong
Apr 6, 1989·The New England Journal of Medicine·D SteinbergJ L Witztum
Jan 1, 1989·Free Radical Research Communications·H EsterbauerM Rotheneder
May 1, 1988·The Journal of Clinical Investigation·M F GoD H Alpers
Feb 20, 1986·The New England Journal of Medicine·R Ross
Aug 14, 1986·Biochimica Et Biophysica Acta·V W van HinsberghH J Kempen
Apr 1, 1984·Environmental Health Perspectives·J S Bus, J E Gibson
Sep 1, 1982·Molecular and Cellular Biology·C M GormanB H Howard
Apr 1, 1993·Atherosclerosis·A N KlimovN P Teryukova
Jul 20, 1933·The Journal of General Physiology·L Michaelis, E S Hill

❮ Previous
Next ❯

Citations

Jan 4, 2001·The Journal of Nutritional Biochemistry·H OdaA Yoshida
Sep 1, 1999·Kidney International·M BoazS Smetana
Aug 21, 2007·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·Stefan P J DullensRonald P Mensink
Jan 21, 2006·Metabolism: Clinical and Experimental·Arshag D MooradianKhuram Wadud
Dec 4, 2012·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·Aline M PrietoChristiane P Soares
Oct 16, 2002·Arteriosclerosis, Thrombosis, and Vascular Biology·B Greg BrownAlan Chait
Mar 27, 2001·Current Opinion in Lipidology·V I ZannisD Kardassis
Oct 2, 2012·International Journal of Molecular Medicine·Yong-Sik KimHo-Yeon Song

❮ Previous
Next ❯

Related Concepts

Related Feeds

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.